The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
Open accessAbstract
Therapy resistance and tumour relapse after drug therapy are commonly explained by Darwinian selection of pre-existing drug-resistant, often stem-like cancer cells resulting from random mutations. However, the ubiquitous non-genetic heterogeneity and plasticity of tumour cell phenotype raises the question: are mutations really necessary and sufficient to promote cell phenotype changes during tumour progression? Cancer therapy inevitably spares some cancer cells, even in the absence of resistant mutants. Accumulating observations suggest that the non-killed, residual tumour cells actively acquire a new phenotype simply by exploiting their developmental potential. These surviving cells are stressed by the cytotoxic treatment, and owing to phenotype plasticity, exhibit a variety of responses. Some are pushed into nearby, latent attractor states of the gene regulatory network which resemble evolutionary ancient or early developmental gene expression programs that confer stemness and resilience. By entering such stem-like, stress-response states, the surviving cells strengthen their capacity to cope with future noxious agents. Considering non-genetic cell state dynamics and the relative ease with which surviving but stressed cells can be tipped into latent attractors provides a foundation for exploring new therapeutic approaches that seek not only to kill cancer cells but also to avoid promoting resistance and relapse that are inherently linked to the attempts to kill them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 2×
“…of CSC into multiple cell types, long thought to be an one-way process, supports the emerging notion that CSCs do not represent a static mutant clone but rather a functional state that can be induced in some cells under some conditions (Gupta et al, 2009a; Dirks, 2010; Gerlinger et al, 2012).”
BackgroundNowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255 · cited 1×
“This scheme of preselection due to non-genetic variability followed by later genetic fixation is in essence Waddington’s genetic assimilation (Waddington, 1942; Zhou et al, 2001; Kim et al, 2002).”
BackgroundA Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
Raj, A., & van Oudenaarden, A. (2008) · Cell · doi:10.1016/j.cell.2008.09.050 · Cited by 2,593
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Evolutionary Dynamics: Exploring the Equations of Life
NOWAK, M. A. (2006) · doi:10.2307/j.ctvjghw98 · Cited by 2,438
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Stochasticity in gene expression: from theories to phenotypes
Kærn, M., Elston, T. C., Blake, W. J., & Collins, J. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1615 · Cited by 2,320
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 3×
“This scheme of preselection due to non-genetic variability followed by later genetic fixation is in essence Waddington’s genetic assimilation (Waddington, 1942; Zhou et al, 2001; Kim et al, 2002).”
BackgroundOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
The multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
A Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature · doi:10.1038/nature13121 · Cited by 888
Self-citationTargeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
Cancer stem cells: The challenges ahead
Medema, J. P. (2013) · Nature Cell Biology · doi:10.1038/ncb2717 · Cited by 741
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, M., Salangsang, F., Landman, A. S., Sellers, W. R., Pryer, N. K., Levesque, M. P., Dummer, R., McMahon, M., & Stuart, D. D. (2013) · Nature · doi:10.1038/nature11814 · Cited by 730
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Stem cell origin of cancer and differentiation therapy
Sell, S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.04.007 · Cited by 638
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., et al. (2014) · Nature · doi:10.1038/nature13108 · Cited by 607
Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572
Huang, S., Ernberg, I., & Kauffman, S. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.07.003 · Cited by 556
Self-citationBalachandran, V. P., Cavnar, M. J., Zeng, S., Bamboat, Z. M., Ocuin, L. M., Obaid, H., Sorenson, E. C., Popow, R., Ariyan, C., Rossi, F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2438 · Cited by 521
Cancer stem cells versus phenotype‐switching in melanoma
Hoek, K. S., & Goding, C. R. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00757.x · Cited by 506
Brock, A., Chang, H., & Huang, S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2556 · Cited by 486
Self-citationNon-genetic heterogeneity of cells in development: more than just noise
Huang, S. (2009) · Development · doi:10.1242/dev.035139 · Cited by 485
Self-citationNakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.017 · Cited by 478
A side order of stem cells: the SP phenotype
Challen, G. A., & Little, M. H. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0116 · Cited by 475
Waddington, C. H. (2017) · Routledge eBooks · doi:10.4324/9781315665405 · Cited by 460
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Huang, S., Hölzel, M., Knijnenburg, T., Schlicker, A., Roepman, P., McDermott, U., Garnett, M., Grernrum, W., Sun, C., Prahallad, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.035 · Cited by 430 · cited 2×
“…expressions such as ‘activation of alternative pathways’ that circumvent the blockade by targetselective drug or ‘adaptive resistance’(Abolhoda et al, 1999; Huang et al, 2012; Pardoll, 2012; Tenbaum et al, 2012; Das Thakur et al, 2013; Sun et al, 2014), are used in a hand-waving manner without…”
BackgroundMethodSelf-citationRadiation‐Induced Reprogramming of Breast Cancer Cells
Lagadec, C., Vlashi, E., Della Donna, L., Dekmezian, C., & Pajonk, F. (2012) · STEM CELLS · doi:10.1002/stem.1058 · Cited by 401
Kim, M., Turnquist, H. R., Jackson, J. D., Sgagias, M. K., Yan, Y., Gong, M., Dean, M. C., Sharp, J. G., & Cowan, K. H. (2002) · PubMed · Cited by 397
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
Tenbaum, S. P., Ordóñez-Morán, P., Puig, I., Chicote, I., Arqués, O., Landolfi, S., Fernández, Y., Herance, J. R., Gispert, J. D., Mendizabal, L., et al. (2012) · Nature Medicine · doi:10.1038/nm.2772 · Cited by 386
Chaudhary, P. M., & Roninson, I. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.632 · Cited by 360
Huang, S. (2012) · BioEssays · doi:10.1002/bies.201100031 · Cited by 359
Self-citationDNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Blanpain, C., Mohrin, M., Sotiropoulou, P. A., & Passegué, E. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.012 · Cited by 348
Li, Q.-Q., Xu, J.-D., Wang, W.-J., Cao, X.-X., Chen, Q., Tang, F., Chen, Z.-Q., Liu, X.-P., & Xu, Z.-D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2372 · Cited by 338
Differentiation of malignant to benign cells
Kauffman, S. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Non-Darwinian dynamics in therapy-induced cancer drug resistance
Pisco, A. O., Brock, A., Zhou, J., Moor, A., Mojtahedi, M., Jackson, D., & Huang, S. (2013) · Nature Communications · doi:10.1038/ncomms3467 · Cited by 297
Self-citationYamada, T., Takaoka, A., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., Ochiai, A., & Hirohashi, S. (2000) · PubMed · Cited by 285
Chang, Q., Jurisica, I., Do, T., & Hedley, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4049 · Cited by 272
Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Ciocca, D. R., Fuqua, S. A. W., Lock-Lim, S., Toft, D. O., Welch, W. J., & McGuire, W. L. (1992) · PubMed · Cited by 243
Quasi-potential landscape in complex multi-stable systems
Zhou, J. X., Aliyu, M. D. S., Aurell, E., & Huang, S. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0434 · Cited by 234
Self-citationAbolhoda, A., Wilson, A. E., Ross, H., Danenberg, P. V., BURT, M. E., & Scotto, K. W. (1999) · PubMed · Cited by 231
Abubaker, K., Latifi, A., Luwor, R., Nazaretian, S., Zhu, H., Quinn, M. A., Thompson, E. W., Findlay, J. K., & Ahmed, N. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-24 · Cited by 213
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
Baker, E. K., Johnstone, R. W., Zalcberg, J. R., & El-Osta, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208955 · Cited by 196
Halliday, J., Helmy, K., Pattwell, S. S., Pitter, K. L., LaPlant, Q., Ozawa, T., & Holland, E. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321014111 · Cited by 185
Huang, S. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9435-7 · Cited by 182
Self-citationIyer, R., & Lehnert, B. E. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00068-4 · Cited by 182
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
Scharovsky, O. G., Mainetti, L. E., & Rozados, V. R. (2009) · Current Oncology · doi:10.3747/co.v16i2.420 · Cited by 173
Pirozzi, G., Tirino, V., Camerlingo, R., Franco, R., La Rocca, A., Liguori, E., Martucci, N., Paino, F., Normanno, N., & Rocco, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021548 · Cited by 172
Ionizing Radiation Induces Stemness in Cancer Cells
Ghisolfi, L., Keates, A. C., Hu, X., Lee, D.-K., & Li, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043628 · Cited by 165
Bates, S. E., Mickley, L. A., Chen, Y. N., Richert, N., Rudick, J., Biedler, J. L., & Fojo, A. T. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.10.4337 · Cited by 163
Multistable and multistep dynamics in neutrophil differentiation
Chang, H. H., Oh, P. Y., Ingber, D. E., & Huang, S. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-11 · Cited by 163
Self-citationWnt activation is implicated in glioblastoma radioresistance
Kim, Y., Kim, K., Lee, J., Lee, Y.-A., Kim, M., Lee, S. J., Park, K., Yang, H., Jin, J., Joo, K., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.161 · Cited by 161
Andarawewa, K. L., Erickson, A. C., Chou, W. S., Costes, S. V., Gascard, P., Mott, J. D., Bissell, M. J., & Barcellos-Hoff, M. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1294 · Cited by 161
Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer
Nör, C., Zhang, Z., Warner, K. A., Bernardi, L., Visioli, F., Helman, J. I., Roesler, R., & Nor, J. E. (2014) · Neoplasia · doi:10.1593/neo.131744 · Cited by 158
The role of DNA damage repair in aging of adult stem cells
Kenyon, J. D., & Gerson, S. L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1064 · Cited by 152
Handbook of Evolutionary Thinking in the Sciences
Heams, T., Huneman, P., Lecointre, G., & Silberstein, M. (2014) · Springer eBooks · doi:10.1007/978-94-017-9014-7 · Cited by 147
Stein, U., Jürchott, K., Walther, W., Bergmann, S., Schlag, P. M., & Royer, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100311200 · Cited by 145
Acquired resistance to drugs targeting receptor tyrosine kinases
Rosenzweig, S. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.025 · Cited by 129
Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
Corrêa, S., Binato, R., Rocher, B. D., Castelo-Branco, M. T. L., Pizzatti, L., & Abdelhay, E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-303 · Cited by 116
Camphausen, K. A., Purow, B. W., Sproull, M. T., Scott, T., Ozawa, T., Deen, D. F., & Tofilon, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502887102 · Cited by 109
Bortul, R., Tazzari, P. L., Cappellini, A., Tabellini, G., Billi, A. M., Bareggi, R., Manzoli, L., Cocco, L., & Martelli, A. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402793 · Cited by 102
Pajic, M., Iyer, J. K., Kersbergen, A. J., van der Burg, E., Nygren, A. O. H., Jonkers, J., Borst, P., & Rottenberg, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0041 · Cited by 93
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
Razandi, M., Pedram, A., Jordan, V. C., Fuqua, S. A. W., & Levin, E. R. (2012) · Oncogene · doi:10.1038/onc.2012.335 · Cited by 92
Notarbartolo, M., Cervello, M., Dusonchet, L., Cusimano, A., & D’Alessandro, N. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00834-5 · Cited by 92
Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line
Xue, Z., Yan, H. M., Li, J., Liang, S., Cai, X., Chen, X., Wu, Q., Gao, L., Wu, K., Nie, Y., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23356 · Cited by 75
He, K., Xu, T., Xu, Y., Ring, A., Kahn, M., & Goldkorn, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28341 · Cited by 65
Nonequilibrium Population Dynamics of Phenotype Conversion of Cancer Cells
Zhou, J., Pisco, A. O., Qian, H., & Huang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110714 · Cited by 55
Self-citationJackson, T., Salmiņa, K., Huna, A., Inashkina, I., Jankevics, E., Riekstiņa, U., Kalniņa, Z., Ivanov, A., Townsend, P. A., Cragg, M. S., et al. (2013) · Cell Cycle · doi:10.4161/cc.23285 · Cited by 49
Pisco, A. O., Jackson, D. A., & Huang, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00306 · Cited by 30
Self-citationImpact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells
Stein, U., Fleuter, C., Siegel, F., Smith, J. L., Kopacek, A., Scudiero, D. A., Hite, K. M., Schlag, P. M., Shoemaker, R. H., & Walther, W. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.81 · Cited by 26
The War on Cancer: Lessons from the War on Terror
Huang, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00293 · Cited by 25
Self-citationLee, G., Shim, J., Cho, B., Jung, J., Lee, D.-S., & Oh, I. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0734-2 · Cited by 20
Conceptualizing a tool to optimize therapy based on dynamic heterogeneity
Liao, D., Estévez-Salmerón, L., & Tlsty, T. D. (2012) · Physical Biology · doi:10.1088/1478-3975/9/6/065005 · Cited by 19
Cited by
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Shaffer, S. M., Dunagin, M. C., Torborg, S. R., Torre, E. A., Emert, B., Krepler, C., Beqiri, M., Sproesser, K., Brafford, P. A., Xiao, M., et al. (2017) · Nature · doi:10.1038/nature22794 · Cited by 1,218
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009
Cancer stem cells as key drivers of tumour progression
Ayob, A. Z., & Ramasamy, T. S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0426-4 · Cited by 910
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.025 · Cited by 771
Metadata
- Authors
- Pisco, A. O., & Huang, S.
- Venue
- British Journal of Cancer
- Published
- 2015-05
- Volume
- 112
- Issue
- 11
- Pages
- 1725-1732
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1569513357
- Cited by
- 283
- References
- 93
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.